<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="article-commentary" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">107777</article-id><article-id pub-id-type="doi">10.7554/eLife.107777</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Insight</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="sub-display-channel"><subject>Senescence</subject></subj-group></article-categories><title-group><article-title>Returning aging cells to productivity</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Vaidya</surname><given-names>Rachana S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6120-5056</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>Rachana S Vaidya</bold> is in the Department of Orthopedic Surgery, Washington University in St. Louis, St. Louis, United States</p></bio></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Tang</surname><given-names>Simon Y</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5570-3921</contrib-id><email>simon.tang@wustl.edu</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>Simon Y Tang</bold> is in the Departments of Orthopedic Surgery, Biomedical Engineering, and Mechanical Engineering and Materials Science, Washington University in St. Louis, St. Louis, United States</p></bio></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01yc7t268</institution-id><institution>Department of Orthopedic Surgery, Washington University in St. Louis</institution></institution-wrap><addr-line><named-content content-type="city">St. Louis</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01yc7t268</institution-id><institution>Departments of Orthopedic Surgery, Biomedical Engineering, and Mechanical Engineering and Materials Science, Washington University in St. Louis</institution></institution-wrap><addr-line><named-content content-type="city">St. Louis</named-content></addr-line><country>United States</country></aff></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>08</day><month>07</month><year>2025</year></pub-date><volume>14</volume><elocation-id>e107777</elocation-id><permissions><copyright-statement>© 2025, Vaidya and Tang</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Vaidya and Tang</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-107777-v2.pdf"/><related-article related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.7554/eLife.103073" id="ra1"/><abstract><p>Platelet-derived growth factors can restore the proliferative potential of senescent cells taken from the degenerated intervertebral discs of aged humans.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>senescence</kwd><kwd>platelet-derived growth factors (PDGFs)</kwd><kwd>inflammation</kwd><kwd>intervertebral disc</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Platelet-derived growth factors can restore the proliferative potential of senescent cells taken from the degenerated intervertebral discs of aged humans.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Template</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text><p><bold>Related research article</bold> Zhang C, Diaz-Hernandez ME, Fukunaga T, Sreekala S, Yoon ST, Haglund L, Drissi H. 2025. Therapeutic effects of PDGF-AB/BB against cellular senescence in human intervertebral disc. <italic>eLife</italic> <bold>13</bold>:RP103073. doi: <ext-link ext-link-type="uri" xlink:href="http://doi.org/10.7554/eLife.103073">10.7554/eLife.103073</ext-link>.</p></boxed-text><p>Most people eventually suffer from low back pain. While many factors contribute to this pain, one of the most common culprits is the gradual breakdown of structures in the back called intervertebral discs (<xref ref-type="bibr" rid="bib1">Diwan and Melrose, 2023</xref>). These discs have a unique jelly donut structure with a soft center, known as the nucleus pulposus, surrounded by tough outer rings of annulus fibrosus. Together, these structures absorb shocks and support movement (<xref ref-type="bibr" rid="bib14">Swahn et al., 2024</xref>).</p><p>As we grow older, intervertebral discs lose water and structural integrity. Moreover, in addition to this mechanical decline, more and more cells enter a dysfunctional state called cellular senescence. Senescent cells are metabolically active, but the cycle cell has stopped, so they are unable to divide: instead, they persist in tissue and release a range of damaging molecules in a process known as the senescence-associated secretory phenotype (SASP).</p><p>Cellular senescence serves as a double-edged sword: it can protect the body in acute scenarios by amplifying inflammatory signals, but it can also drive degeneration when the accumulation of senescent cells reaches chronic levels. Senescence is caused by stressors like DNA damage, injury or oxidative stress, and it initially functions as a defense mechanism (<xref ref-type="bibr" rid="bib11">Patil et al., 2018</xref>; <xref ref-type="bibr" rid="bib7">Liu et al., 2020</xref>; <xref ref-type="bibr" rid="bib10">Paramos-de-Carvalho et al., 2021</xref>). However, persistent senescent cells, particularly in aging or chronic disease contexts, become detrimental to our health by secreting inflammatory factors (such as cytokines, chemokines, and various tissue-degrading enzymes) that degrade tissues and perpetuate pathologies like osteoarthritis and disc degeneration (<xref ref-type="bibr" rid="bib5">Jeon et al., 2018</xref>; <xref ref-type="bibr" rid="bib13">Silwal et al., 2023</xref>).</p><p>Senescent cells can be targeted with drugs called senolytics that selectively eliminate them. In a small human trial, a short course of two senolytics (dasatinib and quercetin) reduced senescent cells in individuals with diabetic kidney disease (<xref ref-type="bibr" rid="bib4">Hickson et al., 2019</xref>). In aging mice, the same drugs delayed disc degeneration and preserved tissue structure (<xref ref-type="bibr" rid="bib8">Novais et al., 2021</xref>). However, senolytics have limitations in that their effects depend on timing, and they could have off-target effects on nearby healthy cells. This has spurred interest in drugs called senomorphics that reduce senescence without eliminating the senescent cells themselves, potentially offering a more targeted therapeutic approach (<xref ref-type="bibr" rid="bib15">Wang et al., 2017</xref>; <xref ref-type="bibr" rid="bib6">Le Pelletier et al., 2021</xref>; <xref ref-type="bibr" rid="bib16">Zhang et al., 2023</xref>).</p><p>Now, in eLife, Hicham Drissi (Emory University and the Atlanta VA Medical Center) and colleagues – including Changli Zhang as first author – report that platelet-derived growth factors (PDGFs) can suppress senescent features in human intervertebral disc cells (<xref ref-type="bibr" rid="bib17">Zhang et al., 2025</xref>). PDGFs are best known for their role in wound healing and tissue regeneration, and are abundant in platelet-rich plasma, a treatment that is already used in some clinics for back pain (<xref ref-type="bibr" rid="bib2">Fiani et al., 2021</xref>).</p><p>The team – which also includes researchers from the Emory Orthopaedics &amp; Spine Center and McGill University – isolated nucleus pulposus cells and annulus fibrosus cells from aged, degenerated human discs, and treated them with the AB and BB isoforms of PDGF. Using RNA sequencing, Zhang et al. found that the treatment suppressed genes involved in oxidative stress, mitochondrial dysfunction, and inflammation – which are all hallmarks of senescence. Meanwhile, genes involved in DNA repair and restarting the cell cycle were upregulated, indicating a shift toward a more proliferative, less inflammatory state (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Using platelet-derived growth factors (PDGFs) to target cellular senescence and low back pain.</title><p>(Top): Cellular senescence in the cells of the nucleus pulposus (NP) and the annulus fibrosus (AF) contributes to intervertebral disc (IVD) degeneration and low back pain. Senescent IVD cells (left) display mitochondrial damage, oxidative stress, a senescence-associated secretory phenotype (SASP), SA-β-gal activity, nuclear membrane dysfunction, and cell cycle arrest. These changes promote disc matrix breakdown and pain. (Bottom): Zhang et al. isolated NP cells (circles) and AF cells (elongated shapes) from degenerated human IVDs and treated them with isoforms of recombinant human PDGF (PDGF-AB and PDGF-BB). Treatment with PDGF reduced various markers of senescence (downward green arrows), while increasing production of PDGF receptor alpha (PDGFRA) and restarting the cell cycle. Healthy cells are shown in blue; senescent cells are shown in red.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107777-fig1-v2.tif"/><attrib>Created with <ext-link ext-link-type="uri" xlink:href="https://BioRender.com/26a8917">BioRender</ext-link>.</attrib></fig><p>To validate these results, Zhang et al. created a model of stress-induced premature senescence by exposing healthy disc cells to high doses of X-rays. Subsequent treatment with the PDGF isoforms, particularly PDGF-BB, reduced classical markers of senescence. This treatment also increased the proportion of cells in the DNA synthesis phase, suggesting that PDGF helped to rescue these cells from permanent cell-cycle arrest.</p><p>Interestingly, the effects of PDGF treatment varied between the two compartments of the intervertebral disc. In nucleus pulposus cells, treatment increased levels of a receptor called PDGF receptor alpha and activated Wnt signaling, which helps preserve cell identity under stress. In annulus fibrosus cells, PDGF-BB downregulated genes involved in nerve growth, blood vessel formation, and mechanical strain, all processes that are linked to the pain associated with disc degeneration. While PDGF-BB has previously been shown to reduce cell death in intervertebral discs (<xref ref-type="bibr" rid="bib12">Presciutti et al., 2014</xref>) and delay degeneration in rabbit model (<xref ref-type="bibr" rid="bib9">Paglia et al., 2016</xref>), this is the first study to reveal its anti-senescent effects in human disc cells.</p><p>The effects of PDGF vary by its target cell type. Zhang et al. found that in aged or stressed disc cells, PDGF appears to restore cellular function by dampening pro-senescent pathways and promoting proliferation and repair, giving the cells in intervertebral discs a second chance. However, in mesenchymal cells, it transiently activates SASP-like genes without inducing senescence, likely as part of a normal repair response (<xref ref-type="bibr" rid="bib3">Grigorieva et al., 2021</xref>). This highlights the need to understand cell-type-specific effects when designing senescence-targeted therapies.</p><p>These insights offer clues to how platelet-rich plasma could work in back pain therapy. In addition to easing pain, it might also help modulate senescent cells and restore disc health. Still, questions remain. Can PDGF reverse all forms of senescence, including those from telomere shortening? Can it be delivered effectively into the tissue of intervertebral discs? And how might it affect nearby cells, like immune cells or nerve endings? Answering these questions will require careful consideration and more research.</p><p>The most important takeaway from the work of Zhang et al. is that senescence may not always be a one-way street. Even in old, degenerated discs, some cells may be coaxed back into action. This raises the exciting possibility that chronic back pain may not be inevitable. With the right molecular signals, even aging discs can be productive again.</p></body><back><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diwan</surname><given-names>AD</given-names></name><name><surname>Melrose</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Intervertebral disc degeneration and how it leads to low back pain</article-title><source>JOR Spine</source><volume>6</volume><elocation-id>e1231</elocation-id><pub-id pub-id-type="doi">10.1002/jsp2.1231</pub-id><pub-id pub-id-type="pmid">36994466</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiani</surname><given-names>B</given-names></name><name><surname>Dahan</surname><given-names>A</given-names></name><name><surname>El-Farra</surname><given-names>MH</given-names></name><name><surname>Kortz</surname><given-names>MW</given-names></name><name><surname>Runnels</surname><given-names>JM</given-names></name><name><surname>Suliman</surname><given-names>Y</given-names></name><name><surname>Miranda</surname><given-names>A</given-names></name><name><surname>Nguy</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cellular transplantation and platelet-rich plasma injections for discogenic pain: A contemporary review</article-title><source>Regenerative Medicine</source><volume>16</volume><fpage>161</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.2217/rme-2020-0146</pub-id><pub-id pub-id-type="pmid">33650437</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grigorieva</surname><given-names>O</given-names></name><name><surname>Arbatskiy</surname><given-names>M</given-names></name><name><surname>Novoseletskaya</surname><given-names>E</given-names></name><name><surname>Dyachkova</surname><given-names>U</given-names></name><name><surname>Ishkin</surname><given-names>A</given-names></name><name><surname>Kalinina</surname><given-names>N</given-names></name><name><surname>Efimenko</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Platelet-derived growth factor induces SASP-associated gene expression in human multipotent mesenchymal stromal cells but does not promote cell senescence</article-title><source>Biomedicines</source><volume>9</volume><elocation-id>1290</elocation-id><pub-id pub-id-type="doi">10.3390/biomedicines9101290</pub-id><pub-id pub-id-type="pmid">34680406</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hickson</surname><given-names>LJ</given-names></name><name><surname>Langhi Prata</surname><given-names>LGP</given-names></name><name><surname>Bobart</surname><given-names>SA</given-names></name><name><surname>Evans</surname><given-names>TK</given-names></name><name><surname>Giorgadze</surname><given-names>N</given-names></name><name><surname>Hashmi</surname><given-names>SK</given-names></name><name><surname>Herrmann</surname><given-names>SM</given-names></name><name><surname>Jensen</surname><given-names>MD</given-names></name><name><surname>Jia</surname><given-names>Q</given-names></name><name><surname>Jordan</surname><given-names>KL</given-names></name><name><surname>Kellogg</surname><given-names>TA</given-names></name><name><surname>Khosla</surname><given-names>S</given-names></name><name><surname>Koerber</surname><given-names>DM</given-names></name><name><surname>Lagnado</surname><given-names>AB</given-names></name><name><surname>Lawson</surname><given-names>DK</given-names></name><name><surname>LeBrasseur</surname><given-names>NK</given-names></name><name><surname>Lerman</surname><given-names>LO</given-names></name><name><surname>McDonald</surname><given-names>KM</given-names></name><name><surname>McKenzie</surname><given-names>TJ</given-names></name><name><surname>Passos</surname><given-names>JF</given-names></name><name><surname>Pignolo</surname><given-names>RJ</given-names></name><name><surname>Pirtskhalava</surname><given-names>T</given-names></name><name><surname>Saadiq</surname><given-names>IM</given-names></name><name><surname>Schaefer</surname><given-names>KK</given-names></name><name><surname>Textor</surname><given-names>SC</given-names></name><name><surname>Victorelli</surname><given-names>SG</given-names></name><name><surname>Volkman</surname><given-names>TL</given-names></name><name><surname>Xue</surname><given-names>A</given-names></name><name><surname>Wentworth</surname><given-names>MA</given-names></name><name><surname>Wissler Gerdes</surname><given-names>EO</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Tchkonia</surname><given-names>T</given-names></name><name><surname>Kirkland</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease</article-title><source>EBioMedicine</source><volume>47</volume><fpage>446</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2019.08.069</pub-id><pub-id pub-id-type="pmid">31542391</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeon</surname><given-names>OH</given-names></name><name><surname>David</surname><given-names>N</given-names></name><name><surname>Campisi</surname><given-names>J</given-names></name><name><surname>Elisseeff</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Senescent cells and osteoarthritis: A painful connection</article-title><source>Journal of Clinical Investigation</source><volume>128</volume><fpage>1229</fpage><lpage>1237</lpage><pub-id pub-id-type="doi">10.1172/JCI95147</pub-id><pub-id pub-id-type="pmid">29608139</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Pelletier</surname><given-names>L</given-names></name><name><surname>Mantecon</surname><given-names>M</given-names></name><name><surname>Gorwood</surname><given-names>J</given-names></name><name><surname>Auclair</surname><given-names>M</given-names></name><name><surname>Foresti</surname><given-names>R</given-names></name><name><surname>Motterlini</surname><given-names>R</given-names></name><name><surname>Laforge</surname><given-names>M</given-names></name><name><surname>Atlan</surname><given-names>M</given-names></name><name><surname>Fève</surname><given-names>B</given-names></name><name><surname>Capeau</surname><given-names>J</given-names></name><name><surname>Lagathu</surname><given-names>C</given-names></name><name><surname>Bereziat</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Metformin alleviates stress-induced cellular senescence of aging human adipose stromal cells and the ensuing adipocyte dysfunction</article-title><source>eLife</source><volume>10</volume><elocation-id>e62635</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.62635</pub-id><pub-id pub-id-type="pmid">34544550</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>JW</given-names></name><name><surname>Piersma</surname><given-names>S</given-names></name><name><surname>Tang</surname><given-names>SY</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The age-dependent effect of high-dose X-ray radiation on NFκB signaling, structure, and mechanical behavior of the intervertebral disc</article-title><source>Connective Tissue Research</source><volume>61</volume><fpage>399</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1080/03008207.2019.1703963</pub-id><pub-id pub-id-type="pmid">31875721</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novais</surname><given-names>EJ</given-names></name><name><surname>Tran</surname><given-names>VA</given-names></name><name><surname>Johnston</surname><given-names>SN</given-names></name><name><surname>Darris</surname><given-names>KR</given-names></name><name><surname>Roupas</surname><given-names>AJ</given-names></name><name><surname>Sessions</surname><given-names>GA</given-names></name><name><surname>Shapiro</surname><given-names>IM</given-names></name><name><surname>Diekman</surname><given-names>BO</given-names></name><name><surname>Risbud</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>5213</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-25453-2</pub-id><pub-id pub-id-type="pmid">34480023</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paglia</surname><given-names>DN</given-names></name><name><surname>Singh</surname><given-names>H</given-names></name><name><surname>Karukonda</surname><given-names>T</given-names></name><name><surname>Drissi</surname><given-names>H</given-names></name><name><surname>Moss</surname><given-names>IL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>PDGF-BB delays degeneration of the intervertebral discs in a rabbit preclinical model</article-title><source>Spine</source><volume>41</volume><fpage>E449</fpage><lpage>E458</lpage><pub-id pub-id-type="doi">10.1097/BRS.0000000000001336</pub-id><pub-id pub-id-type="pmid">27064336</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paramos-de-Carvalho</surname><given-names>D</given-names></name><name><surname>Jacinto</surname><given-names>A</given-names></name><name><surname>Saúde</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The right time for senescence</article-title><source>eLife</source><volume>10</volume><elocation-id>e72449</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.72449</pub-id><pub-id pub-id-type="pmid">34756162</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patil</surname><given-names>P</given-names></name><name><surname>Niedernhofer</surname><given-names>LJ</given-names></name><name><surname>Robbins</surname><given-names>PD</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Sowa</surname><given-names>G</given-names></name><name><surname>Vo</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cellular senescence in intervertebral disc aging and degeneration</article-title><source>Current Molecular Biology Reports</source><volume>4</volume><fpage>180</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1007/s40610-018-0108-8</pub-id><pub-id pub-id-type="pmid">30473991</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Presciutti</surname><given-names>SM</given-names></name><name><surname>Paglia</surname><given-names>DN</given-names></name><name><surname>Karukonda</surname><given-names>T</given-names></name><name><surname>Soung</surname><given-names>DY</given-names></name><name><surname>Guzzo</surname><given-names>R</given-names></name><name><surname>Drissi</surname><given-names>H</given-names></name><name><surname>Moss</surname><given-names>IL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>PDGF-BB inhibits intervertebral disc cell apoptosis in vitro</article-title><source>Journal of Orthopaedic Research</source><volume>32</volume><fpage>1181</fpage><lpage>1188</lpage><pub-id pub-id-type="doi">10.1002/jor.22638</pub-id><pub-id pub-id-type="pmid">24841673</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silwal</surname><given-names>P</given-names></name><name><surname>Nguyen-Thai</surname><given-names>AM</given-names></name><name><surname>Mohammad</surname><given-names>HA</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Robbins</surname><given-names>PD</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Vo</surname><given-names>NV</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Cellular senescence in intervertebral disc aging and degeneration: Molecular mechanisms and potential therapeutic opportunities</article-title><source>Biomolecules</source><volume>13</volume><elocation-id>686</elocation-id><pub-id pub-id-type="doi">10.3390/biom13040686</pub-id><pub-id pub-id-type="pmid">37189433</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swahn</surname><given-names>H</given-names></name><name><surname>Mertens</surname><given-names>J</given-names></name><name><surname>Olmer</surname><given-names>M</given-names></name><name><surname>Myers</surname><given-names>K</given-names></name><name><surname>Mondala</surname><given-names>TS</given-names></name><name><surname>Natarajan</surname><given-names>P</given-names></name><name><surname>Head</surname><given-names>SR</given-names></name><name><surname>Alvarez-Garcia</surname><given-names>O</given-names></name><name><surname>Lotz</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Shared and compartment-specific processes in nucleus pulposus and annulus fibrosus during intervertebral disc degeneration</article-title><source>Advanced Science</source><volume>11</volume><elocation-id>e2309032</elocation-id><pub-id pub-id-type="doi">10.1002/advs.202309032</pub-id><pub-id pub-id-type="pmid">38403470</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Yu</surname><given-names>Z</given-names></name><name><surname>Sunchu</surname><given-names>B</given-names></name><name><surname>Shoaf</surname><given-names>J</given-names></name><name><surname>Dang</surname><given-names>I</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Caples</surname><given-names>K</given-names></name><name><surname>Bradley</surname><given-names>L</given-names></name><name><surname>Beaver</surname><given-names>LM</given-names></name><name><surname>Ho</surname><given-names>E</given-names></name><name><surname>Löhr</surname><given-names>CV</given-names></name><name><surname>Perez</surname><given-names>VI</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism</article-title><source>Aging Cell</source><volume>16</volume><fpage>564</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1111/acel.12587</pub-id><pub-id pub-id-type="pmid">28371119</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Pitcher</surname><given-names>LE</given-names></name><name><surname>Prahalad</surname><given-names>V</given-names></name><name><surname>Niedernhofer</surname><given-names>LJ</given-names></name><name><surname>Robbins</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Targeting cellular senescence with senotherapeutics: senolytics and senomorphics</article-title><source>FEBS Journal</source><volume>290</volume><fpage>1362</fpage><lpage>1383</lpage><pub-id pub-id-type="doi">10.1111/febs.16350</pub-id><pub-id pub-id-type="pmid">35015337</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Diaz-Hernandez</surname><given-names>ME</given-names></name><name><surname>Fukunaga</surname><given-names>T</given-names></name><name><surname>Sreekala</surname><given-names>S</given-names></name><name><surname>Yoon</surname><given-names>ST</given-names></name><name><surname>Haglund</surname><given-names>L</given-names></name><name><surname>Drissi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Therapeutic effects of PDGF-AB/BB against cellular senescence in human intervertebral disc</article-title><source>eLife</source><volume>13</volume><elocation-id>RP103073</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.103073</pub-id><pub-id pub-id-type="pmid">39416006</pub-id></element-citation></ref></ref-list></back></article>